Kraig Biocraft Laboratories, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.6M | $-3.4M | $-3.0M | $-3.8M | $-8.0M | $-5.0M | $-2.9M | $-1.2M |
| Depreciation & Amortization | — | — | — | — | — | — | — | $26.6K |
| Depreciation | $25.1K | $26.2K | $27.6K | $28.1K | $26.1K | $28.1K | $30.8K | $26.6K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-1.8M | $-1.8M | $-1.2M | $-1.9M | $-1.8M | $-1.3M | $-1.1M | $-235.0K |
| Investing Activities | ||||||||
| Capital Expenditures | $5.4K | $4.2K | $6.4K | $5.0K | $97.2K | — | $100.8K | $11.4K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $438.0K | $-4.2K | $-6.4K | $-5.0K | $-547.4K | — | $-100.8K | $-11.4K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $2.5M | $-35.2K | $-60.0K | $3.4M | $3.9M | $1.9M | $1.3M | $242.0K |
| Net Change in Cash | $1.1M | $-1.9M | $-1.3M | $1.5M | $1.5M | $691.9K | $111.3K | $-4.5K |
| Free Cash Flow | $-1.8M | $-1.8M | $-1.3M | $-1.9M | $-1.9M | — | $-1.2M | $-246.5K |